Two leading consultants from The Christie Hospital NHS Foundation Trust, one of Europe's leading cancer centres, have been made professors.
Miss Sarah O'Dwyer and Dr Corinne Faivre-Finn have both been honoured with professorships from The University of Manchester.
Miss O'Dwyer who lives in Hale in Manchester, and has worked at The Christie for 20 years, has been appointed clinical professor of surgery at the Institute of Cancer Services at The University of Manchester. Miss O'Dwyer, who specialises in colorectal surgery and peritoneal surface malignancy - the growth of tumour cells on the surfaces of the organs inside the belly cavity, has been honoured for her contribution to the academic work of the faculty of medical and human sciences.
Miss O'Dwyer said: "By taking on the professorship one agrees to become an ambassador for the university in your clinical field. This honour is humbly received. I see it as recognition of the clinical and academic standards of the colorectal and peritoneal team at The Christie, and I hope to use it to further establish the international reputation of the department and the Hospital"
Dr Corinne Faivre-Finn who lives in Didsbury in Manchester, has been appointed Professor of thoracic radiation oncology and has been a Christie consultant for 14 years. Dr Faivre-Finn, who specialises in research and treatment of patients with lung cancer, will spend half of her role conducting research and the other half treating patients at The Christie. Previously a Reader, conducting cancer research trials for The University of Manchester, Dr Faivre-Finn has been recognised for her career in lung cancer research over the last 10 years.
Dr Faivre-Finn said: "I feel extremely honoured and flattered to receive this new title. It is a great privilege to become a professor in a prestigious university. I hope to be able to promote The Christie, The University of Manchester and lung cancer research both in the UK and internationally"
The Christie has a long history of research breakthroughs and our research portfolio includes a range of drug trials across all phases. This ground-breaking research is made possible through the support of our partnership with The University of Manchester, and our specialist research facilities.
The opening of the new Manchester Cancer Research Centre on The Christie site, a £28.5 million state of the art research facility, and a partnership between The Christie, The University of Manchester and Cancer Research UK, will provide space for university cancer researchers as well as clinical trials support staff. This will help us to achieve our vision of personalised cancer treatments, leading directly to better patient outcomes.